BOLD CT event: Wednesday, September 30, 2026
CompanyBoundless Bio, Inc. (BOLD)
EventCT event
DateWednesday, September 30, 2026
MarketUS listing
SourceCT.gov registry · primary source ↗
Est. Completion: 2026-09-30. Status: ACTIVE_NOT_RECRUITING. Title: Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications
Dates are sourced from official registries and filings and can change — estimated dates (marked ~) slip routinely. This page updates automatically when the source registry moves the date. Research information only, not investment advice.
Every date on this page is free — forever.
A free account adds the interactive calendar with US/EU filters and watchlists. Investor (€19/mo) adds Impact Forecasts on each event, date-slip tracking and calendar sync (Google/Apple/Outlook). Pro adds the full analytics stack.